Literature DB >> 19634484

Evaluation of IFN-gamma serum level in nephropatic type 2 diabetic patients.

Reza Nosratabadi1, M K Arababadi, G Hassanshahi, N Yaghini, V Pooladvand, Ali Shamsizadeh, E R Zarandi, H Hakimi.   

Abstract

The present study was aimed to examine the serum level of IFN-gamma in type 2 diabetic patients with nephropatic complications. In this experimental study, serum samples were obtained from 100 type 2 diabetic patients suffering from nephropathy and 100 healthy controls. Serum level of IFN-gamma was analyzed by ELISA. Results of this study showed that the mean serum level of IFN-gamma was 16.09 +/- 2.04 and 4.03 +/- 1.00 pg mL(-1) in nephropathic patients and healthy controls, respectively. Statistical analysis of data showed that the difference in the IFN-gamma serum level was significant between nephropathic patients and controls. Due to the elevated level of IFN-gamma in nephropathic patients, it can be possibly concluded that IFN-gamma is involved in nephropathy complication of type 2 diabetes.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19634484     DOI： 10.3923/pjbs.2009.746.749

Source DB:  PubMed          Journal:  Pak J Biol Sci        ISSN： 1028-8880


  7 in total

1.  Anti-inflammatory and Antioxidative Activities of Safranal in the Reduction of Renal Dysfunction and Damage that Occur in Diabetic Nephropathy.

Authors:  Ömer Hazman; Mehmet Fatih Bozkurt
Journal:  Inflammation       Date:  2015-08       Impact factor: 4.092

2.  Decreased prevalence of lymphatic filariasis among diabetic subjects associated with a diminished pro-inflammatory cytokine response (CURES 83).

Authors:  Vivekanandhan Aravindhan; Viswanathan Mohan; Jayagopi Surendar; Maradana Muralidhara Rao; Nathella Pavankumar; Mohan Deepa; Ramanujam Rajagopalan; Vasanthapuram Kumaraswami; Thomas B Nutman; Subash Babu
Journal:  PLoS Negl Trop Dis       Date:  2010-06-15

Review 3.  Interrelationship Between Periapical Lesion and Systemic Metabolic Disorders.

Authors:  Hajime Sasaki; Kimito Hirai; Christine M Martins; Hisako Furusho; Ricardo Battaglino; Koshi Hashimoto
Journal:  Curr Pharm Des       Date:  2016       Impact factor: 3.116

4.  Immunogenetics of new onset diabetes after transplantation in Kuwait.

Authors:  Mohamed Jahromi; Torki Al-Otaibi; Nashwa Othman; Osama Gheith; Tarek Mahmoud; Prasad Nair; Medhat A Halim; Narayanam Nampoory
Journal:  Diabetes Metab Syndr Obes       Date:  2019-05-20       Impact factor: 3.168

5.  Patterns of Toll-Like Receptor Expressions and Inflammatory Cytokine Levels and Their Implications in the Progress of Insulin Resistance and Diabetic Nephropathy in Type 2 Diabetic Patients.

Authors:  Rofyda H Aly; Amr E Ahmed; Walaa G Hozayen; Alaa Mohamed Rabea; Tarek M Ali; Ahmad El Askary; Osama M Ahmed
Journal:  Front Physiol       Date:  2020-12-23       Impact factor: 4.566

6.  Association of IL-4-590 C>T and IL-13-1112 C>T gene polymorphisms with the susceptibility to type 2 diabetes mellitus.

Authors:  Afaf Alsaid; Mohammed El-Missiry; El-Sayed Hatata; Mohammad Tarabay; Ahmad Settin
Journal:  Dis Markers       Date:  2013-09-09       Impact factor: 3.434

7.  Association of Haemostatic and Inflammatory Biomarkers with Nephropathy in Type 1 Diabetes Mellitus.

Authors:  Caroline Pereira Domingueti; Rodrigo Bastos Fóscolo; Janice Sepúlveda Reis; Fernanda Magalhães Freire Campos; Luci Maria S Dusse; Maria das Graças Carvalho; Karina Braga Gomes; Ana Paula Fernandes
Journal:  J Diabetes Res       Date:  2015-12-06       Impact factor: 4.011
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.